Immunoglobulin Market to Reach $17.50 Bn, Globally, by 2025, at 7.5% CAGR, Says Allied Market Research

Thursday, November 15, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

PORTLAND, Oregon, November 15, 2018 /PRNewswire/ --

Increase in the number of hemophilic

patients, improved immunoglobulin production using advanced technologies, and enhanced purification techniques with better plasma yield, and rise in prevalent diseases such as chronic inflammatory
demyelinating polyneuropathy (CIDP), hypogammaglobulinemia
, and others would drive the growth of the global immunoglobulin market.

     (Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg )

Allied Market Research published a report, titled, Immunoglobulin Market by Application (Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy, Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Idiopathic Thrombocytopenic Purpura, Inflammatory Myopathies, Specific Antibody Deficiency, Guillain-Barre syndrome, and Others), Product Type (IgG, IgA, IgM, IgE, and IgD), and Mode of Delivery (Intravenous and Subcutaneous): Global Opportunity Analysis and Industry Forecast, 2018-2025. The report offers extensive analyses of the key winning strategies, industry dynamics, market size & forecast, competitive landscape, and top investment pockets. As per the report, the global immunoglobulin market garnered $9.85 billion in 2017, and is estimated to reach $17.50 billion by 2025, registering a CAGR of 7.5% from 2018 to 2025.

Surge in geriatric population who are hemophilic, increase in immunoglobulin production using advanced technologies, and use of enhanced purification techniques with better plasma yield drive the growth of the global immunoglobulin market. Furthermore, increase in incidence of diseases such as chronic inflammatory demyelinating polyneuropathy (CIDP), hypogammaglobulinemia, and others supplement the market growth. However, stringent government regulations for immunoglobulin products and side effects associated with the use of immunoglobulin hamper the market growth.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/2586

Hypogammaglobulinemia segment to dominate in terms of revenue by 2025 

Among applications, hypogammaglobulinemia segment contributed the highest market share of 21% in 2017 and is anticipated to maintain its dominance throughout the forecast period. This is attributed to the growing incidence of hypogammaglobulinemia worldwide. However, myasthenia gravis segment is projected to grow at the fastest CAGR of 10.4% from 2018 to 2025. The report also analyzes chronic inflammatory demyelinating polyneuropathy, primary Immunodeficiency diseases, multifocal motor neuropathy, ITP, inflammatory myopathies, specific antibody deficiency, Guillain-Barre syndrome and others segments.

Intravenous segment to dominate through the forecast period 

Among various modes of delivery, the intravenous segment accounted for 90% share of the total market revenue in 2017 and is expected to maintain its dominance through the study period. High bioavailability of immunoglobulins and rapid absorption rate offered by intravenous mode of delivery drive the growth of this segment. On the other hand, the suncutaneous segment would grow at the fastest CAGR of 7.5% during the forecast period.

For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/2586

North America: highest revenue-generating region, LAMEA: fastest growing segment 

North America contributed nearly half of the total market share in 2017 and would continue to maintain its dominance through 2025. The presence of large plasma production units and high adoption of immunoglobulin in the region boost the market growth. However, Latin America, Middle East and Africa (LAMEA) would register the highest CAGR of 10.3% from 2018 to 2025. The other regions analyzed in the study include Asia-Pacific and Europe.

Prominent players of the industry 

The report presents a detailed analysis of the key players of the global immunoglobulin market including, Baxter international Inc., CSL Ltd., Grifols S.A, Octapharma AG, Kedrion Biopharma Inc., LFB group, Biotest AG, China Biologics Products Inc., Shire (Baxalta), and Bayer Healthcare. These players have adopted new product launches, joint ventures, expansions, mergers & acquisitions, partnerships, and collaborations to gain stronghold in the industry.

Access KNOWLEDGE TREE (Premium on-demand, subscription-based pricing model) at: https://www.alliedmarketresearch.com/knowledgetree

Knowledge tree is a cloud-based intelligence platform that offers more than 2,000 selective, off-the-shelf reports on niche markets to enable our clients gain deep insights on the latest trends, dynamic technologies, and emerging application areas. 

Purchase an enterprise user license and get 1 month complimentary access to our Knowledge Tree subscription. Offer valid till 15th November 2018. (*Terms and Conditions apply)

Get subscription: https://www.alliedmarketresearch.com/checkout/794036

Trending Reports: 

Brain Health Supplements Market - Global Opportunity Analysis and Industry Forecast, 2017 - 2023

Nanomedicine Market - Global Opportunity Analysis and Industry Forecast, 2017 - 2023

About Us 

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact: David Correa 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91-20-66346060 Fax: +1(855)550-5975 help@alliedmarketresearch.com

Web: https://www.alliedmarketresearch.com

SOURCE Allied Market Research



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store